These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 6683651)

  • 21. Does ketanserin relieve frostbite?
    Vayssairat M; Priollet P; Hagege A; Housset E; Foray J
    Practitioner; 1986 May; 230(1415):406-8. PubMed ID: 2944086
    [No Abstract]   [Full Text] [Related]  

  • 22. Influence of ketanserin pretreatment on the haemodynamic responses to sternotomy.
    Cashman JN; Thompson MA; Bennett A
    Anaesthesia; 1986 May; 41(5):505-10. PubMed ID: 2942050
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Placebo-controlled double-blind trial of ketanserin in treatment of intermittent claudication.
    De Cree J; Leempoels J; Geukens H; Verhaegen H
    Lancet; 1984 Oct; 2(8406):775-9. PubMed ID: 6148522
    [TBL] [Abstract][Full Text] [Related]  

  • 24. 5-HT2-receptor blockade in the treatment of heart failure. A preliminary study.
    Demoulin JC; Bertholet M; Soumagne D; David JL; Kulbertus HE
    Lancet; 1981 May; 1(8231):1186-8. PubMed ID: 6112531
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The effect of ketanserin in essential hypertension.
    Anderson A; Morgan T; Dumpys R
    Clin Exp Pharmacol Physiol; 1983; 10(3):331-3. PubMed ID: 6627748
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Study with the competitive 5-HT2-serotonergic antagonist ketanserin.
    Ferrara LA; Fasano ML; Rubba P; Soro S; Marotta G; Mancini M
    J Cardiovasc Pharmacol; 1985; 7 Suppl 7():S159-60. PubMed ID: 2412041
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Corynebacterium-induced protection against artificial pulmonary metastases of a syngeneic fibrosarcoma in mice.
    Milas L; Hunter N; Withers HR
    Cancer Res; 1974 Mar; 34(3):613-20. PubMed ID: 4590922
    [No Abstract]   [Full Text] [Related]  

  • 28. Therapeutic benefits of 5-hydroxytryptamine inhibition following pulmonary embolism.
    Huval WV; Mathieson MA; Stemp LI; Dunham BM; Jones AG; Shepro D; Hechtman HB
    Ann Surg; 1983 Feb; 197(2):220-5. PubMed ID: 6824376
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The effect of a selective 5-HT2 antagonist, ketanserin, on the pulmonary responses to Escherichia coli endotoxin.
    Ball HA; Parratt JR; Rodger IW
    Br J Pharmacol; 1983 Oct; 80(2):295-301. PubMed ID: 6360280
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Ketanserin in the treatment of ischemic disease of the lower extremities].
    Gerová Z; Brimichová E; Dzúrik R
    Cas Lek Cesk; 1985 Jul; 124(30):938-41. PubMed ID: 3161617
    [No Abstract]   [Full Text] [Related]  

  • 31. Prophylactic use of ketanserin in a patient with carcinoid syndrome.
    Fischler M; Dentan M; Westerman MN; Vourc'h G; Freitag B
    Br J Anaesth; 1983 Sep; 55(9):920. PubMed ID: 6615683
    [No Abstract]   [Full Text] [Related]  

  • 32. The effect of serotonergic blockade in postpartum preeclamptic patients.
    Montenegro R; Knuppel RA; Shah D; O'Brien WF
    Am J Obstet Gynecol; 1985 Sep; 153(2):130-4. PubMed ID: 2931024
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Control of preeclamptic hypertension by ketanserin, a new serotonin receptor antagonist.
    Weiner CP; Socol ML; Vaisrub N
    Am J Obstet Gynecol; 1984 Jul; 149(5):496-500. PubMed ID: 6377898
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The 5-hydroxytryptamine antagonist ketanserin inhibits the vasoconstrictor activity of per-operative CSF, from subarachnoid haemorrhage patients, on isolated tissues.
    Tagari PC; Kaye AH; Teddy PJ; Schachter M; Adams CB; Boullin DJ
    J Neurol Neurosurg Psychiatry; 1983 Mar; 46(3):214-20. PubMed ID: 6188804
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ketanserin: a selective antagonist of 5-HT2 serotoninergic receptors.
    Van Nueten JM; Leysen JE; Schuurkes JA; Vanhoutte PM
    Lancet; 1983 Feb; 1(8319):297-8. PubMed ID: 6130314
    [No Abstract]   [Full Text] [Related]  

  • 36. Ketanserin in chronic sympathetic dystrophy. An acute controlled trial.
    Bounameaux HM; Hellemans H; Verhaeghe R
    Clin Rheumatol; 1984 Dec; 3(4):556-7. PubMed ID: 6084577
    [No Abstract]   [Full Text] [Related]  

  • 37. Comparative effects of oxygen, nifedipine and ketanserin in hypoxic pulmonary hypertension.
    Hamet A; Král B; Cernohorský D
    Cor Vasa; 1985; 27(6):406-11. PubMed ID: 2936568
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of an oral serotonin antagonist, ketanserin, on plasma ACTH concentrations in Nelson's syndrome.
    Prescott RW; Ratcliffe WA; Taylor PK
    Br Med J (Clin Res Ed); 1984 Sep; 289(6448):787-8. PubMed ID: 6089950
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Role of serotonin in the regulation of the circulatory system].
    Buczko W
    Pol Tyg Lek; 1985 Apr; 40(16):469-72. PubMed ID: 3160011
    [No Abstract]   [Full Text] [Related]  

  • 40. Intrapartum treatment of preeclamptic hypertension by ketanserin--a serotonin receptor antagonist.
    Weiner CP; Gelfan R; Socol ML
    Am J Obstet Gynecol; 1984 Jul; 149(5):576-8. PubMed ID: 6742030
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.